Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (661-670 of 710) with videos related to

Pageof 71
Sort By:
The European Respiratory Journal|April 30, 2021
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertensionHélène Le Ribeuz, Lucie To, Maria-Rosa Ghigna, et al.
The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
The European Respiratory Journal|January 22, 2021
Lung transplantation for sarcoidosis: outcome and prognostic factorsJérôme Le Pavec, Dominique Valeyre, Pierre Gazengel, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
The European Respiratory Journal|December 18, 2020
ERS statement on chronic thromboembolic pulmonary hypertensionMarion Delcroix, Adam Torbicki, Deepa Gopalan, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
Annals of the American Thoracic Society|January 27, 2021
Association between Leflunomide and Pulmonary HypertensionThomas Lacoste-Palasset, Marie-Camille Chaumais, Jason Weatherald, et al.
ERJ Open Research|May 3, 2023
Functional respiratory complaints among COVID-19 survivors: a prospective cohort studyAntoine Beurnier, Laurent Savale, Xavier Jaïs, et al.
Pageof 71

Showing results (661-670 of 710) with videos related to

Sort By:
Pageof 71
The European Respiratory Journal|April 30, 2021
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertensionHélène Le Ribeuz, Lucie To, Maria-Rosa Ghigna, et al.
The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
The European Respiratory Journal|January 22, 2021
Lung transplantation for sarcoidosis: outcome and prognostic factorsJérôme Le Pavec, Dominique Valeyre, Pierre Gazengel, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
The European Respiratory Journal|December 18, 2020
ERS statement on chronic thromboembolic pulmonary hypertensionMarion Delcroix, Adam Torbicki, Deepa Gopalan, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
Annals of the American Thoracic Society|January 27, 2021
Association between Leflunomide and Pulmonary HypertensionThomas Lacoste-Palasset, Marie-Camille Chaumais, Jason Weatherald, et al.
ERJ Open Research|May 3, 2023
Functional respiratory complaints among COVID-19 survivors: a prospective cohort studyAntoine Beurnier, Laurent Savale, Xavier Jaïs, et al.
Pageof 71